Metaplanet
3350
Murata Manufacturing
6981
Mitsui O.S.K. Lines
9104
4
Alt
260A
5
Mitsubishi UFJ Financial Group
8306
JP Stock MarketDetailed Quotes
4875 MediciNova
- 217
- 00.00%
20min DelayMarket Closed May 1 15:30 JST
10.64BMarket Cap-6.00P/E (Static)
223High213Low81.10KVolume217Open217Pre Close17.67MTurnover35452wk High0.19%Turnover Ratio49.05MShares15552wk Low-36.161EPS TTM9.13BFloat Cap1496Historical HighLossP/E (Static)42.09MShs Float129Historical Low-36.161EPS LYR4.61%Amplitude--Dividend TTM1.43P/B100Lot Size--Div YieldTTM
About MediciNova Company
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.
Company Profile
Symbol4875
Company NameMediciNova
Founded2000-09-26
Fiscal Year Ends12-31
Address4275 Executive Square Suite 300
Zip Code105-0003
Phone03-5532-5912
Company Executives
- Name
- Position
- Salary
- Dr. Yuichi Iwaki,M.D.,PhD
- Chairman of the Board, President and Chief Executive Officer
- 1.41M
- Jason J. Kruger
- Chief Financial Officer and Principal Accounting Officer
- --
- David H. Crean, PhD
- Chief Business Officer
- 99.00K
- Dr. Kazuko Matsuda, M.D.,M.P.H.,PhD
- Director and Chief Medical Officer
- 1.00M
- Nicole Lemerond
- Independent Director
- 57.32K
- Carolyn D. Beaver, C.P.A.
- Independent Director
- 57.32K
- Hideki Nagao
- Independent Director
- 57.32K